李晓光;刘明生;崔丽英;
LI Xiao-guang;LIU Ming-sheng;CUI Li-ying;Department of Neurology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院神经科

摘要(Abstract)：

肌萎缩侧索硬化(amyotrophic lateral sclerosis,ALS)是一种进展性神经系统变性疾病。其起病隐袭,进展缓慢,因呼吸衰竭死亡,目前尚无治愈方法。近年来研究表明多种措施可延长患者存活期,提高患者生活质量。为了科学合理地治疗ALS,本文就其临床分型、分期、治疗模式及对ALS病情进展的评估和随访方法进行介绍。
Amyotrophic lateral sclerosis(ALS) is a progressive neurodegenerative disease,characterized by insidious onset,slow progression,and death due to respiratory failure. There is no cure for it. Recent studies show that many measures can prolong the survival of patients with ALS,and improve their quality of life. In order to treat ALS scientifically and rationally,this paper introduces its clinical classification,staging,treatment mode,and methods for evaluating and following up the progress of ALS disease.

关键词(KeyWords)： 肌萎缩侧索硬化;分型;分期;病情评估
amyotrophic lateral sclerosis;phenotype classification;staging;disease outcome evaluation

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李晓光;刘明生;崔丽英;
LI Xiao-guang;LIU Ming-sheng;CUI Li-ying;Department of Neurology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

Email:

DOI:

参考文献(References)：

• [1]Brown RH,Al-Chalabi A.Amyotrophic Lateral Sclerosis[J].N Engl J Med,2017,377:162-172.
• [2]李晓光,崔丽英.肌萎缩侧索硬化手册[M].北京:中国协和医科大学出版社,2013:294.
• [3]Brooks BR.El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis[J].J Neurol Sci,1994,124:96-107.
• [4]Brooks BR,Miller RG,Swash M,et al.El Escorial revisited:revised criteria for the diagnosis of amyotrophic lateralsclerosis[J].Amyotroph Lateral Scler Other Motor Neuron Disord,2000,5:293-299.
• [5]de Carvalho M,Dengler R,Eisen A,et al.Electrodiagnostic criteria for diagnosis of ALS[J].Clin Neurophysiol,2008,119:497-503.
• [6]ChiòA,Calvo A,Moglia C,et al.Phenotypic heterogeneity of amyotrophic lateral sclerosis:a population based study[J].J Neurol Neurosurg Psychiatry,2011,82:740-746.
• [7]Roche JC,Rojas-Garcia R,Scott KM,et al.A proposed staging system for amyotrophic lateral sclerosis[J].Brain,2012,135:847-852.
• [8]ChiòA,Hammond ER,Mora G,et al.Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis[J].J Neurol Neurosurg Psychiatry,2015,86:38-44.
• [9]Tramacere I,Dalla Bella E,ChiòA,et al.The MITOS system predicts long-term survival in amyotrophic lateral sclerosis[J].J Neurol Neurosurg Psychiatry,2015,86:1180-1185.
• [10]Sinaki M,Mulder DW.Rehabilitation techniques for patients with amyotrophic lateral sclerosis[J].Mayo Clin Proc,1978,53:173-178.
• [11]Miller RG,Mitchell JD,Moore DH.Riluzole for amyotrophic lateral sclerosis(ALS)/motor neuron disease(MND)[J].Cochrane Database Syst Rev,2012,3:CD001447.
• [12]Andersen PM,Abrahamsb S,Borasio D,et al.EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis(MALS)—revised report of an EFNS task force[J].Eur J Neurol,2012,19:360-375.
• [13]Miller RG,Jackson CE,Kasarskis EJ,et al.Practice parameter update:The care of the patient with amyotrophic lateral sclerosis:drug,nutritional,and respiratory therapies(an evidence-based review):report of the Quality Standards Subcommittee of the American Academy of Neurology[J].Neurology,2009,73:1218-1226.
• [14]Bensimon G,Lacomblez L,Meininger V.A controlled trial of riluzole in amyotrophic lateral sclerosis.ALS/Riluzole Study Group[J].N Engl J Med,1994,330:585-591.
• [15]Hardiman O,van den Berg LH,Kiernan MC.Clinical diagnosis and management of amyotrophic lateral sclerosis[J].Nat Rev Neurol,2011,7:639-649.
• [16]Cedarbaum JM,Stambler N,Malta E,et al.The ALSFRSR:a revised ALS functional rating scale that incorporates assessments of respiratory function.BDNF ALS Study Group(Phase III)[J].J Neurol Sci,1999,169:13-21.
• [17]Maier A,Holm T,Wicks P,et al.Online assessment of ALS functional rating scale compares well to in-clinic evaluation:a prospective trial[J].Amyotroph Lateral Scler,2012,13:210-216.
• [18]Küffner R,Zach N,Norel R,et al.Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression[J].Nat Biotechnol,2015,33:51-57.
• [19]Jenkinson C,Levvy G,Fitzpatrick R,et al.The amyotrophic lateral sclerosis assessment questionnaire(ALSAQ-40):tests of data quality,score reliability and response rate in a survey of patients[J].J Neurol Sci,2000,180:94-100.
• [20]Swinnen B,Robberecht W.The phenotypic variability of amyotrophic lateral sclerosis[J].Nat Rev Neurol,2014,10:661-670.